Thanks for pointing that out is they can quickly h

Thanks for pointing that out is they can quickly have access to the 50% interim data on Jan 12th there will be more than enough positive efficiency data and Safety data for a quick turnaround on EUA. I think the main reason FDA hasn’t given it yet is it would compromise trial. Once it does not interfere with trial data we should see an immediate EUA. Full approval won’t come until full data analysis is compiled and sent in.